Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 22:24:111-117.
doi: 10.1016/j.phro.2022.10.002. eCollection 2022 Oct.

Feasibility of artificial-intelligence-based synthetic computed tomography in a magnetic resonance-only radiotherapy workflow for brain radiotherapy: Two-way dose validation and 2D/2D kV-image-based positioning

Affiliations

Feasibility of artificial-intelligence-based synthetic computed tomography in a magnetic resonance-only radiotherapy workflow for brain radiotherapy: Two-way dose validation and 2D/2D kV-image-based positioning

Siti Masitho et al. Phys Imaging Radiat Oncol. .

Abstract

Background and purpose: Magnetic Resonance Imaging (MRI)-only workflow eliminates the MRI-computed tomography (CT) registration inaccuracy, which degrades radiotherapy (RT) treatment accuracy. For an MRI-only workflow MRI sequences need to be converted to synthetic-CT (sCT). The purpose of this study was to evaluate a commercially available artificial intelligence (AI)-based sCT generation for dose calculation and 2D/2D kV-image daily positioning for brain RT workflow.

Materials and methods: T1-VIBE DIXON was acquired at the 1.5 T MRI for 26 patients in RT setup for sCTs generation. For each patient, a volumetric modulated arc therapy (VMAT) plan was optimized on the CT, then recalculated on the sCT; and vice versa. sCT-based digitally reconstructed radiographs (DRRs) were fused with stereoscopic X-ray images recorded as image guidance for clinical treatments. Dosimetric differences between planned/recalculated doses and the differences between the calculated and recorded clinical couch shift/rotation were evaluated.

Results: Mean ΔD50 between planned/recalculated doses for target volumes ranged between -0.2 % and 0.2 %; mean ΔD50 and ΔD0.01ccm were -0.6 % and 1.6 % and -1.4 % and 1.0 % for organ-at-risks, respectively. Differences were tested for clinical equivalence using intervals ±2 % (dose), ±1mm (translation), and ±1° (rotation). Dose equivalence was found using ±2 % interval (p < 0.001). The median differences between lat./long./vert. couch shift between CT-based/sCT-based DRRs were 0.3 mm/0.2 mm/0.3 mm (p < 0.05); median differences between lat./long./vert. couch rotation were -1.5°/0.1°/0.1° (after improvement of RT setup: -0.4°/-0.1°/-0.4°, p < 0.05).

Conclusions: This in-silico study showed that the AI-based sCT provided equivalent results to the CT for dose calculation and daily stereoscopic X-ray positioning when using an optimal RT setup during MRI acquisition.

Keywords: Artificial intelligence; Brain radiotherapy; MRI-only workflow; Synthetic CT; kV-image-based positioning.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
The colorwash of the planned dose distribution on image datasets. (a) Planned dose distribution on the planning CT and (b) on the reconstructed AI-based synthetic CT of the brain (bone windowing, W = 1600, L = 450).
Fig. 2
Fig. 2
Dosimetric evaluation of sCT-based plan compared to CT-based plan. (a) Percentage deviation of D50 (ΔD50[%]) of target volumes and organ-at-risks (OAR); and (b) percentage deviation of D0.01ccm (ΔD0.01[%]) of OARs. The color bar represents the dose deviation. Values for TPCT→sCT are indicated with circular (filled) markers, whereas TPsCT→CT are indicated with rectangular (unfilled) markers.
Fig. 3
Fig. 3
Evaluation of PTV coverage of sCT-based plan compared to CT-based plan. (a) The PTV coverage (conformity index (CI)) of TPCT→sCT and (b) of TPsCT→CT; (b) the PTV coverage differences between planned and recalculated dose using the two evaluation methods.
Fig. 4
Fig. 4
Comparison of sCT-based DRR and CT-based DRR on the 2D/2D kV-X-ray-based patient setup verification system. (a) DRR-X-ray registration at ExacTrac system using CT (top) and sCT (bottom). (b) (Left) couch shift difference (T: translation) and (right) couch rotation difference (R: rotation) for each patient in lateral, longitudinal, and vertical direction. Blue dashed line represents the 0 value (no deviation). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)

References

    1. Putz F., Mengling V., Perrin R., Masitho S., Weissmann T., Rosch J., et al. Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfalls. Strahlenther Onkol. 2020;196:444–456. doi: 10.1007/s00066-020-01604-0. - DOI - PMC - PubMed
    1. Ulin K., Urie M.M., Cherlow J.M. Results of a multi-institutional benchmark test for cranial CT/MR image registration. Int J Radiat Oncol Biol Phys. 2010;77:1584–1589. doi: 10.1016/j.ijrobp.2009.10.017. - DOI - PMC - PubMed
    1. Masitho S., Putz F., Mengling V., Reissig L., Voigt R., Bauerle T., et al. Accuracy of MRI-CT registration in brain stereotactic radiotherapy: Impact of MRI acquisition setup and registration method. Z Med Phys. 2022 doi: 10.1016/j.zemedi.2022.04.004. - DOI - PMC - PubMed
    1. Hanvey S., Sadozye A.H., McJury M., Glegg M., Foster J. The influence of MRI scan position on image registration accuracy, target delineation and calculated dose in prostatic radiotherapy. Br J Radiol. 2012;85:e1256–e1262. doi: 10.1259/bjr/26802977. - DOI - PMC - PubMed
    1. Hanvey S., McJury M., Tho L.M., Glegg M., Thomson M., Grose D., et al. The influence of MRI scan position on patients with oropharyngeal cancer undergoing radical radiotherapy. Radiat Oncol. 2013;8:129. doi: 10.1186/1748-717X-8-129. - DOI - PMC - PubMed